BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16415423)

  • 1. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma.
    Ha PK; Hdeib A; Goldenberg D; Jacene H; Patel P; Koch W; Califano J; Cummings CW; Flint PW; Wahl R; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):12-6. PubMed ID: 16415423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
    Goyal P; Hsu JM; Kellman RM
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):694-9. PubMed ID: 19128678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
    Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
    Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer.
    Gourin CG; Williams HT; Seabolt WN; Herdman AV; Howington JW; Terris DJ
    Laryngoscope; 2006 May; 116(5):705-10. PubMed ID: 16652075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.
    Jeong HS; Baek CH; Son YI; Ki Chung M; Kyung Lee D; Young Choi J; Kim BT; Kim HJ
    Head Neck; 2007 Mar; 29(3):203-10. PubMed ID: 17111430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does PET imaging add to conventional staging of head and neck cancer patients?
    Pohar S; Brown R; Newman N; Koniarczyk M; Hsu J; Feiglin D
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):383-7. PubMed ID: 17379443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
    J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.
    Connell CA; Corry J; Milner AD; Hogg A; Hicks RJ; Rischin D; Peters LJ
    Head Neck; 2007 Nov; 29(11):986-95. PubMed ID: 17563906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
    Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
    J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT significance for planning radiotherapy of head and neck cancer.
    Kolarova I; Vanasek J; Kandrnal V; Odrazka K; Dusek L; Chrobok V; Belohlavek O; Dolezel M; Petruzelka L; Michalek R; Jarkovsky J
    Neoplasma; 2012; 59(5):536-40. PubMed ID: 22668019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography in the management of unknown primary head and neck carcinoma.
    Miller FR; Hussey D; Beeram M; Eng T; McGuff HS; Otto RA
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):626-9. PubMed ID: 16027287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.